Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 76282-816

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 76282-816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals,inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 1. (Fig 1)

Fig 1. (Fig 1)
FDA Label Image

Fig 2. (Fig 2)

Fig 2. (Fig 2)
This document provides information on drug interactions involving Methotrexate, Midazolam, Oral Contraceptives (Levonorgestrel, Ethinyl Estradiol), and Metformin. It includes details on their interactions as CYP3A substrates, CT & MATE substrates, as well as pharmacokinetics parameters such as AUC and Cmax. The document also mentions the ratio relative to references and their corresponding confidence intervals.*
FDA Label Image

Fig 3. (Fig 3)

Fig 3. (Fig 3)
FDA Label Image

Fig 4. (Fig 4)

Fig 4. (Fig 4)
This is a brief description of a study comparing response rates between XELIANZ 5mg taken twice daily and a placebo over a 6-month period. The results are likely presented in a table or chart format.*
FDA Label Image

Fig 5. (Fig 5)

Fig 5. (Fig 5)
FDA Label Image

Fig 6. (Fig 6)

Fig 6. (Fig 6)
FDA Label Image

Label. (Label)

Label. (Label)
This is a product description for Tofacitinib Extended-Release Tablets with NDC 76282-816-30. Each film-coated extended-release tablet contains 17.77 mg of tofacitinib citrate (equivalent to 11 mg of tofacitinib). It is advised to dispense the enclosed Medication Guide to each patient. The tablets should be stored at 20°C to 25°C (68°F to 77°F) and not be repackaged. The product is manufactured by Orient Pharma Co., Ltd. in Taiwan and distributed by Exelan Pharmaceuticals, Inc. in Boca Raton, FL. For dosage and usage information, refer to the accompanying prescribing information.*
FDA Label Image

Structure. (Structure)

Structure. (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.